Arslan 2013 |
54 |
87.0 |
I-II |
16.4 ± 4.4 |
Laryngeal microsurgery |
Sevoflurane |
1 - Lidocaine 10% spray |
No reduction in cough incidence and laryngospasm. Agitation lower in lidocaine group. |
|
|
|
|
14.9 ± 5.3 |
|
|
2 - Saline spray |
|
Bousselmi 2014 |
80 |
Sex ratio 1.2 to 2.3 |
I-III |
82 ± 34 |
Not described |
Propofol + Remifentanil |
1 - Saline instillation + saline cuff |
Reduction in cough incidence and sore throat. |
|
|
|
|
80 ± 42 |
|
|
2 - Saline instillation + lidocaine cuff |
|
|
|
|
|
72 ± 32 |
|
|
3 - Lidocaine instillation + saline cuff |
|
|
|
|
|
76 ± 36 |
|
|
4 - Lidocaine instillation + lidocaine cuff |
|
D’Aragon 2013 |
116 |
0% |
I-II |
30-120 |
Elective gynecologic procedure |
Desflurane |
1 - 4% lidocaine 4 mL spray + lidocaine cuff |
Reduction in cough incidence (NNT 3.05). No influence in sore throat. |
|
|
All female |
|
|
|
|
2 - 4% lidocaine 4 mL spray + NS cuff |
|
|
|
|
|
|
|
|
3 - NS spray + lidocaine cuff |
|
|
|
|
|
|
|
|
4 - NS spray + NS cuff |
|
Diachun 2001 |
46 |
Not described |
I-III |
Not described |
Non ear, nose and throat surgery |
Isoflurane |
1 - Lidocaine 2% TT 2 mg.kg-1 spray |
Reduction in cough incidence. |
|
|
|
|
|
|
+N2O |
2 - Saline 4 mL |
|
|
|
|
|
|
|
|
3 - Nothing |
|
Dutta 2016 |
45 |
42.2 |
I-III |
Not described |
Not decribed |
Sevoflurane |
1 - Lidocaine 10% TT 1.5 mg.kg-1
|
No reduction in cough and extubation time |
|
|
|
|
|
|
|
2- NS i.v + NS spray |
|
|
|
|
|
|
|
|
3 - Dex 0.3 ug. kg-1 + NS spray |
|
Fang 2018 |
52 |
25.0 |
I-II |
Until 4 hours |
Thyroidectomy |
Propofol + Remifentanil |
1 - Ropivacaine 0,75% 6 mL |
Reduction in cough. No influence on sore throat and extubation time. |
|
|
|
|
|
|
|
2 - Saline 6 mL |
|
Gupta 2006 |
50 |
Not described |
Not described |
Not described |
Carotid endarterectomy |
Volatile |
1 - Lidocaine 4% 4 mL TT |
Reduction in cough. |
|
|
|
|
|
|
|
2 - NS 4 mL TT |
|
Jee 2003 |
75 |
70.6 |
Not described |
106.8 ± 44.7 |
Orthopaedic, plastic, lower abdominal surgery |
Enflurane |
1 - No drug |
Reduction in number of coughs (5 and 10 min). |
|
|
|
|
123.4 ± 55.9 |
|
|
2 - Lidocaine 2% TT 1 mg.kg-1 spray 5 min before extubation |
|
|
|
|
|
103.6 ± 40.8 |
|
|
3 - IV lidocaine 1 mg.mL-1
|
|
Lee 2011 |
55 |
61.8 |
I |
28.9 ± 7.2 |
Laryngeal microscopic surgery |
Sevoflurane + N2O |
1 - Lidocaine 10% TT 1.5 mg.kg-1
|
No reduction in cough incidence, reduction in number of coughs. |
|
|
|
|
30.1 ± 7.9 |
|
|
2 - No treatment |
|
Li 2016 |
322 |
56.5 |
I-III |
90.7 ± 23.6 |
Urology, otolaryngology, ophthalmologic, orthopedic |
Sevoflurane |
Lidocaine 2% TT 4 mg.kg-1
|
Reduction in cough, laryngospasm, desaturation. No influence on extubation time. |
|
|
|
|
86.9 ± 30.3 |
|
|
Saline 0,9% 4 mL |
|
Paltura 2018 |
64 |
45.3 |
I |
20 to 25 min |
Suspension laryngoscopy for benign laryngeal diseases |
Sevoflurane |
1 - Lidocaine 10% spray 7 puffs |
No reduction in cough incidence and extubation time. Agitation lower in lidocaine spray group. |
|
|
|
|
|
|
|
2 - Lidocaine 2% 1 mL (cotton swap) |
|
|
|
|
|
|
|
|
3 - Control (nothing applied) |
|
Shabnum 2017 |
60 |
61.6 |
I-II |
240 ± 18.67 |
Craniotomies |
Isoflurane |
1 - IV Lignocaine 2% 1.5 mg.kg-1 + intratracheal placebo |
Reduction in cough incidence. No influence in extubation time. |
|
|
|
|
244.5 ± 16.08 |
|
|
2 intratracheal lignocaine 2% 1.5 mg.kg-1 + IV placebo |
|
|
|
|
|
265 ± 18.17 |
|
|
3 - IV + intratracheal placebo |
|
Soltani 2002 |
204 |
57.8 |
I-II |
45 ± 0.6 |
Cataract surgery |
Halothane + N2O |
1 - lidocaine 10% spray distal end ETT |
I.V. lidocaine promotes reduction in cough incidence. No influence in extubation time. |
|
|
|
|
|
|
|
2 - lidocaine 10% spray laryngopharyngeal structures |
|
|
|
|
|
|
|
|
3 - 2% lidocaine jelly ETT |
|
|
|
|
|
|
|
|
4 - i.v. Lignocaine 2% 1.5 mg.kg-1 at the end of surgery |
|
|
|
|
|
|
|
|
5 - 2% lidocaine intracuff |
|
|
|
|
|
|
|
|
6 - normal saline end ETT |
|
Yamasaki 2013 |
60 |
45.0 |
I-II |
124 ± 52 |
Tympanoplasty |
Propofol + Remifentanil |
1 - Lidocaine 4% 3 mL transtracheal |
Reduction in cough/severe cough. |
|
|
|
|
226 ± 54 |
|
|
2 - No medication |
|
Zamora Lozano 2007 |
78 |
48.7 |
I-II |
60-120 min |
General, gynaecology, orthopedic, ophtalmological, plastic, urological |
Volatile |
1 - Lidocaine 2% TT 5 mL |
Reduction in cough. |
|
|
|
|
|
|
|
2 - Lidocaine 2% IV 5 mL |
|
|
|
|
|
|
|
|
3 - Saline 0,9% 5 mL |
|
|
|
|
|
|
|
|
4 - Lidocaine 2% 5 mL intracuff |
|